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Depression Scale (HADS) in a large sample of
French employees
Christine Boc?r?an 1* and Emilie Dupret2Abstract
Background: The Hospital Anxiety and Depression Scale (HADS) is a questionnaire widely used for detecting
anxiety and depressive disorders. It is used extensively in France, but has never been the subject of a full study in a
population at work. The objectives of this study were to present some psychometric properties of the HADS on a
large sample of French employees.
Method: The HADS questionnaire was given to salaried employees at 19 major French companies as part of their
biennial occupational medical examination. In 2011, 20992 employees filled in the questionnaire. HADS ? s structure
was studied first by exploratory, then confirmatory factorial analyses.
Results: The model selected was the original two-factor structure. The two subscales showed good internal
consistency. Women scored higher than the men for anxiety and depression; the scores increased with age;
engineers and managers had lower average scores than other occupational status (blue- or white-collar workers
and technicians).
Conclusion: The results of the analyses are consistent with those in literature relating to other populations studied
in other countries. The HADS questionnaire is pertinent for detecting symptoms of anxiety and depression in a
population of people at work.
Keywords: Hospital Anxiety and Depression Scale (HADS), Validation study, EmployeesBackground
The publication of the Hospital Anxiety and Depression
Scale (HADS) in 1983 [1] triggered off a large number
of significant research studies. There is therefore an
abundant literature on the subject. This tool has been
translated and validated in many countries and its cap-
acity to detect anxiety and depressive disorders is widely
recognized. Nonetheless, as soon as it was published,
researchers rightly questioned the structure of the ques-
tionnaire, its links with the other tools for determining
anxiety and depression and its psychometric properties
in general. In the first instance, we shall present the
points on which there seems to be a consensus, followed
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article, unless otherwise stated.HADS comprises 14 items, seven of which relate to anx-
iety symptoms and seven to depressive symptoms. Each
item is coded from 0 to 3. The scores for anxiety and de-
pression can therefore vary from 0 to 21, depending on the
presence and severity of the symptoms. The authors [1]
have proposed cut-off points or thresholds: a score be-
tween 0 and 7 does not indicate the presence of the symp-
toms of anxiety or depression; a score between 8 and 10
indicates the presence of the symptomology but to a mod-
erate degree, therefore doubtful cases; a score greater than
or equal to 11 indicates a significant number of symptoms
of anxiety or depression corresponding to confirmed cases.
The studies concerning the accuracy of these thresholds
all showed them to be reliable: the review of the literature
by Bjelland et al. [2], covering 747 papers, concluded that
the threshold of 8 is decisive in order to not exclude people
suffering from anxiety or depressive disorders, which
would be the case if the threshold of 10 alone was takenCentral. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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the sensitivity and specificity of the HADS: This tool was
proposed in Norway to a general population in the doctor's
consulting room [3], in England with people suffering from
heart disease [4] and to a representative sample of the Ger-
man population [5], the threshold of 8 is highly recom-
mended for each of the two scales. More recently, Roberge
et al. [6] calculated different thresholds relating to each
scale: 10 or more for the anxiety scale, 7 or more for the
depression scale. When the HADS is considered on one
scale only, a possibility envisaged but not recommended
by Zigmond and Snaith [1] as a measure of the intensity of
? emotional distress ? , the recommended threshold is 13 [5],
even 16 [6].
The concurrent validity of each of the two HADS
scales, HADS Depression subscale (HADS-D) and HADS
Anxiety subscale (HADS-A), has been demonstrated with
populations suffering from various pathologies, in differ-
ent countries and with a variety of methodologies: Clinical
interviews and/or standardized tools. Thus, high correla-
tions were found between the scores on the Beck Depres-
sion Inventory and the HAD-D scores in diabetic patients
[7], in elderly people in hospital, people attending hospital
consultations and people in the general population [8] or
in patients suffering from cancer [9], to quote only the
most recent studies. The Depression Screening Ques-
tionnaire has also been used to check the concurrent
validity of the HADS-D scale in the patients of general
practices [3], and the Quality of Life Questionnaire in
Iranian patients suffering from different stages of cancer
[10] or people suffering frommusculoskeletal disease [11].
Regarding anxiety, the two principal questionnaires used
are the State-Trait Anxiety Inventory and the Generalized
Anxiety Questionnaire [3,8].
However, the HADS-D and HADS-A are not independ-
ent: according to Bjelland et al. [2], the average correlation
would be .56, which is not astonishing, given the comor-
bidity between anxiety and depressive pathologies. The
main symptommeasured by the HADS-D relates to an an-
hedonic depression. So, the correlation between sub-score
is estimated, in the general population, at between .5 and .6
[12] and is clearly higher in the populations suffering from
pathologies, which the vast majority of the studies in-
volved. For this reason, some authors recommend the use
of HADS-A to assess both anxious and depressive symp-
toms [7,13]. It should, however, be remembered that the
meta analysis produced by Mitchell, Meader and Symonds
[13] involved only patients suffering from cancer and in
palliative care, for whom it can easily be understood that
anxiety symptoms are closely intertwined with depressive
symptoms; the same argument can be advanced for the
study by Sultan, Luminet and Hartemann [7] which con-
cerns diabetics, for whom the depressive experience is
highly marked by anxiety. Others, that we have alreadymentioned, recommend the use of the global scale to
assess the intensity of emotional distress (e.g. [5,7,13-16]).
The few divergences we have just mentioned are not,
however, subject to significant debate. On the other
hand, they are revealing about a point on which the au-
thors are not in agreement, that is to say the factorial
structure of the HADS. This has been under discussion
for almost 30 years and the debate is still ongoing.
Zigmond and Snaith [1] drew up the HADS with two ob-
jectives: i) retain only items ? based solely on the psychic
symptoms of neurosis ? (p. 362), ii) ? to define carefully and
distinguish between the concepts of anxiety and depres-
sion ? (id.). This is in order to evaluate the disorders more
related to the patients' psychological symptoms rather
than physical ones. Thus, the depressive dimension is
strongly marked by the measure of anhedonia (five items
out of seven), a characteristic symptom of depression, and
the anxiety dimension by the measure of feelings of ten-
sion, worry, fear and panic (five items out of seven). None-
theless, some of these ten items can give an account of
both an emotional state and a physical state as well as the
two supplementary items that complete each of the scales.
We can estimate that these items do not fully meet the au-
thors' first objective and we shall see that these are the
items that are subject to discussion in the majority of
cases.
Although some research studies point to a structure
with four factors [17,18] or a single factor [5,7,13-16],
the main debate concerns two or three factors (cf. litera-
ture review of Cosco et al. [19]). Martin [20] deems that
we have to take the negative linguistic form of some
items into consideration either as a general factor influ-
encing the factors of anxiety and depression, or as a
supplementary factor. Others take the tripartite model
of Clark and Watson [21,22] as a basis and obtain a more
satisfactory factorial solution by considering three
factors: An anxiety factor, a depression factor and a
negative emotional or psychomotor agitation factor
[14,23-28]. Lastly, a large number of research studies
point to the initial two-factor structure of HADS
[2,3,7-9,12,13,29-40]. Nonetheless, it is difficult, a priori,
to adopt a position in favor of one or the other, given the
very diverse populations involved in the analyses (wit-
ness the debate between Friedmann et al. and Dahl et al.
[41] and the different statistical methods used (EFA -
with orthogonal or oblique rotation - or CFA). In
addition, the study by Straat, Andries van der Ark and
Sijtsma [42] shows that the differences obtained by the
authors in respect of the dimensional structure of the
HADS are essentially due to methodological factors.
However, Norton et al. [43] present a meta confirmatory
factor analysis by which they tested 10 models; although
they prefer the solution with a general distress factor,
they conclude that a bifactorial model is acceptable.
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the HADS on a large population of French employees and
to see whether we obtain the same main results as in the
literature. The population in our research is original, since
it concerns working employees; it is assumed to be in bet-
ter health than all the other populations. There is no study
relating to this type of population. Also, this questionnaire
is very often used by companies in France (we specify the
context in the next paragraph) without there being any
previous psychometric analyses done on such data.
We shall compare our results with the studies involving
a general population only [2,5,23,31,33,34] and with a
small number of existing French studies [7,14,26,44-46].
Methods
Study population
The data were gathered throughout 2011 in 19 major
French companies, some of which are established on
different sites, representing a total of 32 different French
towns (in the Paris area and the other regions). They












In 70% of cases, it is company head offices which are
concerned, the remaining 30% being production sites. The
professions of employees within head offices are rela-
tively similar, even though the companies' businesses are
different (e.g. Purchasing/marketing/sales; assistance/sec-
retarial; accounting/management/finance; legal; commu-
nications; human resources, etc.). On production sites,
jobs differ according to the nature of the business. In the
whole of our sample (n = 20992), we counted more than
100 different jobs.
Study instruments
The HADS comprises fourteen items: seven items meas-
ure symptoms of anxiety (HADS-A) and seven items
measure symptoms of depression (HADS-D). Each item
is coded 0 to 3, which gives a score varying between 0 and
21 for each scale. The version used is the French version
introduced by Lepine et al. [45] and used since by Ravazi
et al. [14], Friedman et al. [25] or Untas et al. [40], for
example.The HADS was preceded by socio-demographic ques-
tions. We kept the variables common to the companies. In
this way, we possess information relative to gender, age
category and occupational status for all our population.
Study procedure
In the companies that we work with and in the French
legal framework for preventing psychosocial risks, the
occupational health service administers questionnaires
to all the employees during their medical examination
on a dedicated computer. One of the questionnaires is
the HADS and employees have the ability to print out
their scores; this means that they can discuss them im-
mediately with the doctor.
Other questionnaires are also offered to employees but
they differ from company to company: thus, some em-
ployees complete the Cohen Perceived Stress Scale [47]
in 10 or in 4 items and/or a questionnaire measuring
psychosocial risks, the Copenhagen Psychosocial Ques-
tionnaire [48]. The execution was computerized and the
data collected was fully anonymous.
Once a year, usually, companies ask us for a global ana-
lysis, by type, by age, by job, etc. and we report the results
to the medical and social partners. We also participate, if
the company so wishes, in setting up action plans with
groups of employees who obtained the lowest scores.
The employees were free to respond or not, but given
the context, more than 95% responded, representing a
total 20992 people who fully completed the HADS in
2011.
Statistical analysis
Exploratory Factor Analyses (EFAs) were carried out on
all the participants and on several subgroups on SPSS
18.0. The rotation requested was oblique (oblimin rota-
tion) given that the factors are correlated.
The results of the EFAs show that there are several pos-
sible factorial solutions. We tested these models with Con-
firmatory Factor Analysis (CFA) conducted on Lisrel 8.8.
We take as our basis the two recommended indicators [49]
(that are Root Mean Square Error of Approximation
(RMSEA), and Adjusted Goodness of Fit Index (AGFI)
which corrects Goodness of Fit Index (GFI) depending on
the number of degrees of freedom. A good fit between the
theoretical model and the data should be expressed as an
RMSEA lower than .05 [50], or even .08 [51] the AGFI
should be greater than .90 [52] or even .95 [49].
We then proceeded to carry out a reliability analysis
by measuring the internal consistency using Cronbach's
alpha and calculating the scale-item correlations (SPSS
18.0). We checked that the scores obtained were com-
patible with those of the literature by means of variance
analyses (SPSS 18.0) and presented the mean scores by
subgroup (gender, age and status). Given the size of the
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thus the effect sizes (Eta-square, η2).
Results
Validity analysis: factorial structure
We carry out an EFA on all the subjects that leads to ex-
traction of three factors, which account for 37.6%, 9% and
8% of variance (corresponding eigenvalues were 5.3, 1.3
and 1.05). But according to Costello and Osborne [53], this
method often overestimates the number of factors: they
thus suggest fixing the number of factors manually and
comparing the item loading tables. They also give criteria
to choose the ? cleanest solution ? : i) item loading above .30,
ii) no or few item crossloading and iii) no factors with
fewer than three items. So we have explored a two- and
three-factor solution (cf. Table 1).
Quite similar patterns of results are obtained for all
subsets (women, men, and the four age groups) with one
exception. In women subset analyses, we find the original
two-factor solution of Zigmond and Snaith [1]. In other
analyses, differences lie in small variations of loadings
which do not alter the overall pattern and HAD7-A4 and
HAD8-D4 items load cross the two or three factors in the
sameway.
The three-factor solution reveals two of three disad-
vantages quoted by the authors: factor 3 consists only of
two items and HAD7-A4 and HAD14-D7 items load
cross two or three factors. The two-factor solution pre-
sents only one disadvantage: HAD7-A4 and HAD8-D4
items load cross the two factors.Table 1 Loading of HADS Items for the Two- and Three-factor
HADS Item
Anxiety subscale
HAD1-A1 I feel tense or ? wound up ?
HAD3-A2 I get a sort of frightened feeling as if something awful is abo
HAD5-A3 Worrying thoughts go through my mind
HAD7-A4 I can sit as ease and feel relaxed
HAD9-A5 I get a sort of frightened feeling like ? butterflies? in the stoma
HAD11-A6 I feel restless as I have to be on the move
HAD13-A7 I get sudden feelings of panic
Depression subscale
HAD2-D1 I still enjoy the things I used to enjoy
HAD4-D2 I can laugh and see the funny side of things
HAD6-D3 I feel cheerful
HAD8-D4 I feel as if I am slowed down
HAD10-D5 I have lost interest in my appearance
HAD12-D6 I look forward with enjoyment to things
HAD14-D7 I can enjoy a good book or TV programWe thus choose the two-factor model. We propose to
test four models of CFA which take into account all the
possible combinations of HAD7-A4 and HAD14-D7
items belonging to one or other factor (cf. Table 2).
Table 3 shows the indicators associated with each
model tested.
All the Χ2 have a high value and are significant, which
is not surprising given the amount of data. There is no
model which distinguishes itself in a more favorable way
than the other one: every four models quite similar fits.
Some authors consider the values of these indices to be
satisfactory [52]. Nonetheless, they can be improved by
allowing correlations between the error variances be-
tween some items and the factors or between items
themselves. We choose to improve the model 1 because
both two links proposed by the program to lower most
the Χ2 value are respectively the one between HAD8-D4
item and factor 2 and that between HAD7-A4 item and
factor 1.
This last analysis shows an X2 (74) value of 6372.5
(p < .001), a RMSEA equal to .06 and an AGFI of .96,
which almost meets the highest constraints [49,51].
Other numerous links are proposed between items,
which would allow us to improve still adjustment indica-
tors. Nevertheless, we prefer to stop there for three rea-
sons: i) the present factorial structure is enough good to
report data, ii) it also reports loadings of HAD8-D4 and
HAD7-A4 items on factors 1 and 2, as suggested it the
EFAs, and iii) we know well that items and factors are in-
ter correlated; it is not thus necessary to weigh down theModel (items crossloading are in bold)
Two-Factor solution Tree-Factor solution
F1 F2 F1 F2 F3
.54 -.70 .49 -.68 .31
ut to happen .46 -.75 .44 -.76 .08
.52 -.78 .47 -.77 .27
.47 -.38 .40 -.28 .73
ch .42 -.80 .39 -.81 .13
.19 -.50 .09 -.35 .67
.40 -.79 .36 -.79 .15
.72 -.33 .73 -.36 .09
.78 -.46 .78 -.48 .14
.66 -.46 .65 -.47 .14
.41 -.41 .44 -.48 -.25
.60 -.29 .58 -.31 .08
.80 -.39 .81 -.41 .11
.57 -.29 .53 -.23 .51
Table 2 Description of theoretical models tested by CFA (distribution of the HADS items on the factors); the items that
load substantially on two factors are in bold
Items Model 1 (original model) Model 2 Model 3 Model 4
Fact1 Fact2 Fact1 Fact2 Fact1 Fact2 Fact1 Fact2
HAD2-D1 x x x x
HAD4-D2 x x x x
HAD6-D3 x x x x
HAD8-D4 x x x x
HAD10-D5 x x x x
HAD12-D6 x x x x
HAD14-D7 x x x x
HAD1-A1 x x x x
HAD3-A2 x x x x
HAD5-A3 x x x x
HAD7-A4 x x x x
HAD9-A5 x x x x
HAD11-A6 x x x x
HAD13-A7 x x x x
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RMSEA lower than .05. Figure 1 represents the factor
structure of the HADS.
Reliability analysis: internal consistency
The internal consistency of the two scales is good. Con-
cerning the depression scale, Cronbach's alpha is .78 and
the scale/item correlations vary from .54 (HAD8-D4) to
.77 (HAD12-D6). Concerning the anxiety scale, Cronba-
ch's alpha is .81 and the scale/item correlations vary from
.56 (HAD7-A4 and HAD11-A6) to .78 (HAD5-A3). The
anxiety and depression scores are correlated at .62.
Validity analysis: known groups comparison
The sample is composed of 38.5% of women; the age
categories are as follows: 21% of employees are of less than
30 years old, 33.4% from 30 to 39 years old, 28.8% from 40
to 49 years old and 20.8% are more 50 years old. The occu-
pational status categories are as follows: 50.5% are blue- or
white-collar Workers and Technicians (WT), 49.5% areTable 3 Adjustment indicators of the different models
tested
Χ2 (df), p* RMSEA AGFI
Model 1 7078.8 (76), < .001 .067 .94
Model 2 6923.2 (76), < .001 .066 .94
Model 3 7186.8 (76), < .001 .067 .94
Model 4 6977.8 (76), < .001 .067 .94
*Χ2: Chi-squared (number of degrees of freedom), significance threshold.middle (engineers or junior executives) or upper Manage-
ment (top executives) (Ma). The WT have on average a
level of study lower than second-year University, Ma have
a level of study upper.
Several studies have highlighted the differences in anx-
iety and/or depression scores depending on gender and age
using the HADS [5,26,33,54]. These differences are to be
found in the population we used (cf. Table 4). Women have
a higher average anxiety score than men (F(1, 20990) =
515.8, p < 0.001, η2 = .03); the same is true of the depression
score (F(1, 20990) = 32.5, p < 0.001, η2 = .002). The anxiety
score increases with age (F(3, 20988) = 37.4, p < 0.001,
η2 = .005) as does the depression score (F(3, 20988) =
128.3, p < 0.001, η2 = .02). It should be noted, however,
that not all the age groups differ two by two concerning
the anxiety score (Bonferroni's Post-Hoc tests): score of
employees from 40 to 49 years old does not differ from
that of those of more than 50 years old.
We also find the expected differences between em-
ployees of different occupational status [55,56]: WT have
anxiety (F(1, 20990) = 72.3, p < 0.001, η2 = .003) and de-
pression scores (F(1, 20990) = 237.2, p < 0.001, η2 = .01)
significantly higher than managers.
Average scores according to gender, age group and
occupational status
The size of our sample allows us to give indicative scores for
the population of French employees according to gender,
age and occupational status. Tables 5 and 6 present the
average scores of anxiety and depression of the employees
































Figure 1 Factor structure of HADS. The dotted arrows indicate the correlations recommended by the model for improvement; in bold italics,
the r2 associated with each scale.
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After carrying out EFAs on all the people in our sample, as
well as the sub-groups defined according to gender and
age, we used CFA to test the different possible theoretical
models. It turns out that the original model, as defined by
Zigmond and Snaith [1] is the one that demonstrates the
best fit. This is therefore the one we selected at least for the
population we are interested in, that is to say, French
employees.
In EFAs, two types of items are observed: items which
substantially load one of the two factors and two items with
smaller loadings that load the two factors. Thus, HAD2-D1,
HAD4-D2, HAD6-D3, HAD10-D5, HAD12-D6 and
HAD14-D7 items have a loading that varies from .57 to .80
on factor 1, which we identify as accounting for the scale of
depression. Factor 2, corresponding to the anxiety scale,
comprises HAD1-A1, HAD3-A2, HAD5-A3, HAD9-A5,
HAD11-A6 and HAD13-A7 items whose loadings varyfrom -.50 to -.80. Two items HAD8-D4 and HAD7-A4 do
not clearly load on one of the two factors.
We propose to test four models of CFA: the original
model and the three others which take into account all the
possible combinations of items HAD8-D4 and HAD7-A4
belonging to one or other factor (cf. Table 2). The chosen
model is the original two-factor model but, to obtain a
good adequacy of the model with the data, we have of to
add a link between HAD8-D4 and the anxiety factor as
well as a link between HAD7-A4 and depression factor;
what was expected according to the results of the EFAs.
These items are often quoted in the literature as having no
weight satisfying on the factor to which they are supposed
to belong (e.g. [8-10,38,39]). Roberge et al. [6] list the vari-
ous interpretations mentioned by authors in literature (p.
176? 177): the item HAD7-A4, in its formulation, refers to
the anxious symptomatology ? I cannot sit at ease ? and to
depressive symptoms related to anhedonia ? I cannot feel
Table 4 Mean (M) and Standard Deviation (SD) of the
anxiety and depression scores of subgroups
HADS-A HADS-D
Subgroup Mean SD Mean SD
Sex
Female 6.55 3.8 3.48 3.2
n = 8072
Male 5.42 3.3 3.22 3.0
n = 12920
Age
Under 30 5.39 3.3 2.64 2.6
n = 4399
30 to 39 5.85 3.5 3.21 3.0
n = 7008
40 to 49 6.06 3.6 3.62 3.3
n = 5215
50 and over 6.09 3.6 3.84 3.4
n = 4370
Occupational status
WT 6.06 3.7 3.65 3.3
n = 10606
Ma 5.65 3.4 2.98 3
n = 10386
Table 5 Mean (M) and standard deviation (SD) of the anxiety
age group and occupational status (WT: blue- or white-collar
executives and upper Management)
Female M(SD)
Age according occupational status
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about the psychic and motor slowing, which may be a
symptom of depression, ( ? I feel as if I am slowed down ? ), it
can also be reminiscent of the anxious inhibition some-
times present in the anxious spectrum [57].
Nevertheless, even if we did not find the ? true? original
model, we consider that we can continue to base ourselves
on the calculation of the scores according to Zigmond and
Snaith [1] with seven items relative to the depression and
seven items relative to the anxiety. Indeed, there have been
a large number of studies concerning the thresholds calcu-
lated from the initial anxiety and depression scales. These
studies [2-5] have largely validated the use of thresholds
(one threshold at 8 and another at 11) and a calling into
question of the calculation of anxiety and depression
scores necessarily calls into question the value of the
thresholds. The last reason is related to our sample: the
HADS was devised a priori for detecting the presence of
anxiety and depressive disorders in hospital patients. Al-
though the two-factor structure was also found in general
populations [3,5,8,33,34], our sample is not fully compar-
able to a general population because it only concerns
people at work. However, when we compare groups (ac-
cording to gender, age, occupational status and especially
other variables specific to each company, such as business
line or department), using initial anxiety and depression
scores or scores based only on the five items that most load
the anxiety (HAD1-A1, HAD3-A2, HAD5-A3, HAD9-A5
and HAD13-A7) and depression factors (HAD2-D1,score of subgroups of employees according to gender,
Workers and Technicians; Ma: engineers or junior
Male M(SD)
Age according occupational status
















Table 6 Mean (M) and standard deviation (SD) of the depression score of subgroups of employees according to
gender, age group and occupational status (WT: blue- or white-collar Workers and Technicians; Ma: engineers or junior
executives and upper Management)
Female M(SD) Male M(SD)
Age according occupational status Age according occupational status
Under 30 WT 2.88 (2.9) Under 30 WT 2.74 (2.7)
n = 1361 n = 1327
Ma 2.41 (2.5) Ma 2.34 (2.4)
n = 695 n = 1016
30 to 39 WT 3.66 (3.2) 30 to 39 WT 3.54 (3.2)
n = 1535 n = 2014
Ma 3.05 (3.0) Ma 2.69 (2.6)
n = 1229 n = 2230
40 to 49 WT 4.16 (3.6) 40 to 49 WT 4.02 (3.3)
n = 1034 n = 1341
Ma 3.61 (3.3) Ma 3.08 (3.0)
n = 859 n = 1981
50 and over WT 4.33 (3.6) 50 and over WT 4.45 (3.5)
n = 894 n = 1100
Ma 3.99 (3.5) Ma 3.22 (3.1)
n = 465 n = 1911
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global results are unchanged: We find exactly the same
groups with the highest scores. As the important aspect of
our psychosocial risk prevention approach is to detect "at
risk" groups, the scores calculated on the initial scales
remain valid and wemay, in addition, use the thresholds.
We presented the averages of the scores of anxiety and
depression by subgroups (by crossing gender, age group
and status). We cannot exactly compare these results in
detail with the results published in the literature, with the
exception of a few studies that validated the questionnaire
with a general population [5,34] or included a control
group taken from the general population [8,15]. The over-
all mean values and themean values by gender (when these
are given) are either comparable to those of this study, or
slightly higher, as in the case of the German validation
study [5] for the depression score; in the latter case, the
population was older than the one in our study, which ac-
counts for the differences. Nevertheless, we can note that
women have a higher score of anxiety on average than men
(6.55 vs 5.42) and that the scores of anxiety and especially
depression increase with the age (HADS-A: 5.39 for the
30-year-old employees less vs 6.09 for those of 50 and
more years old; HADS-D: 2.64 for the 30-year-old em-
ployees less vs 3.84 for those of 50 andmore years old). Oc-
cupational status also impacts scores: in every age group,
blue- or white-collar workers and technicians have anxiety
and depression scores higher than those of engineers or
junior executives and upper Management. For example,anxiety (depression) mean score for employees from 30 to
39 years old is 6.14 (3.62) for blue- or white-collar workers
and technicians vs 5.55 (2.83) for engineers or junior exec-
utives and upper Management. The influence of the gen-
der can be illustrated by the difference between anxiety
scores of women and the men who are more than 50 years
old: if we mention these differences with cut-off defined by
Zigmond and Snaith [1], 18.4% of women have a score
upper to 11 versus 9% of men. Occupational status influ-
ence can be illustrated in its turn by the difference between
depression scores of the employees who are more than
50 years old: 6.8% of blue- or white-collar workers and
technicians have a score upper to 11 versus 3.7% of man-
agers. These results are consistent with those found in lit-
erature; we cite in particular Cohidon [57] who reports the
results of the SMPG "Mental health in the general popula-
tion" survey conducted between 1999 and 2003 on a sam-
ple of 36,000 people in France. The questionnaire used was
the Mini [58]. The author reports that mood disorders
affect 11% of men and 16% of women; anxiety disorders
17% of men and 25% of women. Analysis of the data shows
equal and systematic differences according to socio-
professional category: the least qualified persons are those
most affected by disorders. The hypothesis which we are
able to put forward (which concerns our results and also
Cohidon's) is that persons on a lower socio-economic level
have a more restricted access to care, whether in financial
terms and/or on a personal level [59,60]. Actually, the gen-
eral practitioner remains the preferred point of contact for
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reluctant to approach a psychiatrist or psychologist (the
latter is never covered by health insurance in France).
Limitations of the study
The way in which these data were gathered has its advan-
tages and disadvantages and determines the limits of this
study. Indeed, the circumstances in which they are gath-
ered is the yearly or two-yearly examination by the com-
pany doctor. The high rate of participation comes from the
fact that people are more convinced of the anonymity of
their responses when information is given to the work-
place health department. Furthermore, employees have
the ability to print out their scores, in order to discuss
them with the doctor who, in all cases, addresses the sub-
ject with the employee. But the very fact of completing a
questionnaire in the workplace can necessarily produce a
bias which we can observe, given that all our data are col-
lected in the same context. The employee can attempt to
minimize his/her scores for anxiety or depression symp-
toms, just as he/she can do the opposite. According to the
doctors whom we meet regularly, the HADS helps them to
detect incipient anxiety or depression problems: an em-
ployee who scores higher than 10 or 11 in an interview on
one of the two scales present, behavior which will leave no
doubt in the doctor's mind on the necessity of asking more
detailed questions on personal or work-related problems;
an employee with a score of between 8 and 11 will attract
the doctor's attention and he/she will go into more detail
to determine whether the employee is actually presenting
symptoms resulting from anxiety or depression.
From a psychometric point of view, it has not been pos-
sible to verify a number of elements. Given that employees'
responses are completely anonymous, it is impossible to
do a test and retest, to improve the degree of accuracy.
Similarly, convergent validity can only be addressed by re-
ports from doctors and their experience. Actually, in this
situation, it is not possible to offer employees different
questionnaires relating to other measurements for anxiety
and depression, so as to test their concurring validity.
Finally, we do not have many independent variables; for
example, we would have wished to know the level of stud-
ies of our subjects to make comparisons with the litera-
ture; we have not the exact age (but only groups of age)
and no information on the personal life of the subjects.
Conclusion
The findings from this study are consistent with the ana-
lyses conducted with other populations in other countries:
the HADS has good reliability and discriminant validity;
its bi-dimensional structure allows one score to be calcu-
lated for anxiety symptoms and one score for depression
symptoms. However, as Straat, Andries van der Ark and
Sijtsma [42] suggest, and given the recurring results for theproblem items, perhaps this questionnaire should be
reviewed.
However, the HADS remains a useful instrument for de-
tecting anxiety and depression symptoms, both at an indi-
vidual and a collective level. As we have explained, the
individual level is not within our remit but that of the com-
pany doctor. On the other hand, we are more particularly
interested at a collective level in the context of preventing
psychosocial risks. The population covered by this study is
obviously not representative of all French employees, since
our data practically only concerns major companies.
Nevertheless, we update our data every year and we can
compare a given company with all the other companies on
"our panel", obviously taking into consideration the char-
acteristics of each of them (gender, age, etc.). We therefore
see a wide variability between the average scores for anx-
iety and depression in companies: for example, for 2011
data, the average anxiety score varies between 10.3 (SD =
4.4) and 5.11 (SD = 3.07); the average depression score var-
ies between 6.37 (SD = 4.07) and 2.51 (SD = 2.45). Most of
the time, this great variability is due to the economic situ-
ation in that business sector; the variability within a com-
pany (between different jobs or different departments)
results more from internal characteristics (management
policy, training, etc.).
The last report drafted by experts and asked by the
French Ministry of Employment and Health shows that
the anxious and depressive disorders are the ones which
are the most present in the population of employees,
that they recover from psychosocial risk factors and that
it is thus important to measure them [61]. Even if the
HADS is criticized [42], it remains a quick and relevant
tool for use in companies.
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